[Study on the interaction between Clostridium perfringens and the host].


Journal

Nihon saikingaku zasshi. Japanese journal of bacteriology
ISSN: 1882-4110
Titre abrégé: Nihon Saikingaku Zasshi
Pays: Japan
ID NLM: 2984804R

Informations de publication

Date de publication:
2021
Historique:
entrez: 18 11 2021
pubmed: 19 11 2021
medline: 20 11 2021
Statut: ppublish

Résumé

Clostridium perfringens type A causes gas gangrene, which is a serious disease caused by wound infection. α-Toxin produced by C. perfringens is known to be the primary pathogenic factor of gas gangrene. Although it has been proposed to induce tissue damage by impairing the host immune system and peripheral circulation, sufficient findings have not been obtained to explain the high virulence of C. perfringens. For the purpose of elucidating the pathogenic mechanism of this bacterium, I focused on the disease progressions such as the bacterial colonization, muscle tissue destruction and repair, and sepsis. In this review, focusing on the action of α-toxin, it will be explained together with the latest research results that the toxin suppresses the activation of the host immune response, represents toxicity to vascular endothelial cells, induces peripheral circulatory disorders due to hematopoietic disorders, inhibits muscle tissue repair, and induces excessive immune response. These mechanisms suggest that α-toxin acts in multiple steps to disrupt host defense and that C. perfringens attacks the host with a highly sophisticated mechanism. It is expected that the onset mechanism of gas gangrene would be elucidated, and I hope that new therapeutic strategies are developed.

Identifiants

pubmed: 34789601
doi: 10.3412/jsb.76.149
doi:

Substances chimiques

Bacterial Toxins 0
Calcium-Binding Proteins 0

Types de publication

Journal Article Review

Langues

jpn

Sous-ensembles de citation

IM

Pagination

149-160

Auteurs

Masaya Takehara (M)

Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH